Allozymes
-
DATABASE (5)
-
ARTICLES (3)
With Allozymes technology, designing industrial enzymes takes months instead of years, helping industries from pharmaceuticals to foodtech get the chemicals they need much faster.
With Allozymes technology, designing industrial enzymes takes months instead of years, helping industries from pharmaceuticals to foodtech get the chemicals they need much faster.
Co-founder and CTO of Allozymes
Akbar Vahidi is an Iranian researcher turned entrepreneur based in Singapore. After graduating in 2010 with a bachelor’s in chemical engineering from Sharif University of Technology, he pursued a PhD in chemical and biomolecular engineering at the National University of Singapore (NUS). Vahidi earned his PhD in 2015 and briefly worked as a research fellow at Nanyang Technological University before returning to NUS to pursue research.At NUS, he was a part of a research group that developed a new enzyme screening method based on microfluidics technology. With fellow NUS PhD graduate Peyman Salehian, Vahidi secured an exclusive license to use the technology and established Allozymes, a startup that offers enzyme engineering services. Vahidi became the CTO of Allozymes.
Akbar Vahidi is an Iranian researcher turned entrepreneur based in Singapore. After graduating in 2010 with a bachelor’s in chemical engineering from Sharif University of Technology, he pursued a PhD in chemical and biomolecular engineering at the National University of Singapore (NUS). Vahidi earned his PhD in 2015 and briefly worked as a research fellow at Nanyang Technological University before returning to NUS to pursue research.At NUS, he was a part of a research group that developed a new enzyme screening method based on microfluidics technology. With fellow NUS PhD graduate Peyman Salehian, Vahidi secured an exclusive license to use the technology and established Allozymes, a startup that offers enzyme engineering services. Vahidi became the CTO of Allozymes.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
Co-founder and CEO of Allozymes
Peyman Salehian is an Iranian-born entrepreneur trained in chemical and biomolecular engineering. He founded his first company in 2010 after developing a custom material, and sold his stake in the company in 2013 before pursuing a PhD in Chemical and Biomolecular engineering at the National University of Singapore (NUS).Salehian graduated from the PhD program in 2017 and worked as a research fellow before embarking on one-year stints at two Singapore companies. In late 2019, he and fellow NUS researcher Akbar Vahidi established Allozymes, a startup offering enzyme engineering services using NUS-developed technology under license, with Salehian as CEO and Vahidi as CTO.
Peyman Salehian is an Iranian-born entrepreneur trained in chemical and biomolecular engineering. He founded his first company in 2010 after developing a custom material, and sold his stake in the company in 2013 before pursuing a PhD in Chemical and Biomolecular engineering at the National University of Singapore (NUS).Salehian graduated from the PhD program in 2017 and worked as a research fellow before embarking on one-year stints at two Singapore companies. In late 2019, he and fellow NUS researcher Akbar Vahidi established Allozymes, a startup offering enzyme engineering services using NUS-developed technology under license, with Salehian as CEO and Vahidi as CTO.
Xora Innovation is a subsidiary of the Singapore sovereign investment fund, Temasek. It was established as an early-stage deeptech investment platform that identifies startups connected with the Singapore science and technology ecosystem (although the startup can be based anywhere in the world). Xora plans to invest as a lead or co-lead in seed or Series A rounds, with later-stage investments being handled through Temasek. As of July 2021, Xora has invested in two companies based in Singapore: Allozymes, which provides enzyme engineering services, and Nuevocor, which is developing gene therapy for certain heart diseases.
Xora Innovation is a subsidiary of the Singapore sovereign investment fund, Temasek. It was established as an early-stage deeptech investment platform that identifies startups connected with the Singapore science and technology ecosystem (although the startup can be based anywhere in the world). Xora plans to invest as a lead or co-lead in seed or Series A rounds, with later-stage investments being handled through Temasek. As of July 2021, Xora has invested in two companies based in Singapore: Allozymes, which provides enzyme engineering services, and Nuevocor, which is developing gene therapy for certain heart diseases.
Allozymes wants to supercharge manufacturing with engineered enzymes
The Future Food Asia 2021 award winner speeds up enzyme engineering from years to months, is already attracting clients and has just raised $5m seed funding
Future Food Asia 2021: Two winners take home $100,000 each
Agrifood startups, corporations and investors urged to collaborate and take action, tackling challenges in nutrition and climate change
Future Food Asia 2021 announces finalists for $100,000 prize
Ten startups from agrifood tech and cleantech sectors will pitch during the five-day conference, are also eligible for two more prizes from sponsors Cargill and Thai Wah
Sorry, we couldn’t find any matches for“Allozymes”.